Literature DB >> 28685542

Continuous blood purification in children with severe sepsis.

X H Guo1, Y F Sun2, S Z Han1, J Miao1, M Cui1, J B Wang1.   

Abstract

This study aims to analyse the clinical effects of continuous blood purification (CBP) in children with severe sepsis to form a basis for CBP application in this context. One hundred and twenty children with severe sepsis treated in Binzhou People’s Hospital, Shandong, China, from June 2013 to June 2014 were divided into two groups, a treatment and a control group, depending on parental preference. The control group was treated conventionally, and the treatment group underwent CBP in addition to conventional therapy. Cardiovascular and respiratory parameters were measured on admission and after 72 h. This study also assayed interleukin (IL)-8 and tumour necrosis factor (TNF)-α levels, and monitored clinical outcomes and prognosis. The cardiovascular and respiratory parameters of the treatment group improved to a significantly greater extent than did those of the control group (all P less than 0.05). After treatment, the levels of IL-8, IL-6, IL-10, and TNF-α declined in both groups, but more so in the treatment group (all P<0.05). The white blood cell count and C-reactive protein level fell more in the treatment than control group, with statistical significance (both P less than 0.05). CBP remarkably improved the cardiovascular and respiratory functions of children with severe sepsis, probably by eliminating factors mediating inflammation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28685542

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  3 in total

1.  Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children.

Authors:  Scott L Weiss; Mark J Peters; Waleed Alhazzani; Michael S D Agus; Heidi R Flori; David P Inwald; Simon Nadel; Luregn J Schlapbach; Robert C Tasker; Andrew C Argent; Joe Brierley; Joseph Carcillo; Enitan D Carrol; Christopher L Carroll; Ira M Cheifetz; Karen Choong; Jeffry J Cies; Andrea T Cruz; Daniele De Luca; Akash Deep; Saul N Faust; Claudio Flauzino De Oliveira; Mark W Hall; Paul Ishimine; Etienne Javouhey; Koen F M Joosten; Poonam Joshi; Oliver Karam; Martin C J Kneyber; Joris Lemson; Graeme MacLaren; Nilesh M Mehta; Morten Hylander Møller; Christopher J L Newth; Trung C Nguyen; Akira Nishisaki; Mark E Nunnally; Margaret M Parker; Raina M Paul; Adrienne G Randolph; Suchitra Ranjit; Lewis H Romer; Halden F Scott; Lyvonne N Tume; Judy T Verger; Eric A Williams; Joshua Wolf; Hector R Wong; Jerry J Zimmerman; Niranjan Kissoon; Pierre Tissieres
Journal:  Intensive Care Med       Date:  2020-02       Impact factor: 17.440

2.  Serum Cystatin C Level Monitoring for Intervention Opportunity of CBP in Children with Severe Sepsis.

Authors:  Weikai Wang; Yi Qiang; Zhongbin Tao; Baowang Yang; Bin Yan; Xilong Chen; Ruifeng Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650

3.  Hemofiltration Successfully Eliminates Severe Cytokine Release Syndrome Following CD19 CAR-T-Cell Therapy.

Authors:  Yanfen Liu; Xinfeng Chen; Dao Wang; Hong Li; Jianmin Huang; Zhen Zhang; Yingjin Qiao; Hongling Zhang; Ying Zeng; Chao Tang; Shuangning Yang; Xiaochun Wan; Youhai H Chen; Yi Zhang
Journal:  J Immunother       Date:  2018 Nov/Dec       Impact factor: 4.456

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.